Gene expression profile of the A549 human non-small cell lung carcinoma cell line following treatment with the seeds of descurainia sophia, a potential anticancer drug

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Kim, Bu Yeo ^a   Lee, Jun ^a   Park, Sung Joon ^a   Bang, Ok Sun ^a   Kim, No Soo ^a  

^a Korea Institute of Oriental Medicine (KIOM)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

DESCURAINIA SOPHIA EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG;

ARTICLE; CANCER CHEMOTHERAPY; CARCINOMA CELL; CONTROLLED STUDY; DESCURAINIA SOPHIA; DOSE RESPONSE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; LUNG NON SMALL CELL CANCER; MEDICINAL PLANT; MICROARRAY ANALYSIS; PLANT SEED; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION;

EID: 84880174225     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/584604     Document Type: Article

References (33)

1. Ghavami G., Kazemali M. R., Sardari S., Informatics of drug synergism in naturally occurring anticancer agents. Recent Patents on Anti-Cancer Drug Discovery 2011 6 1 26 44 2-s2.0-78650934857 10.2174/157489211793980105
2. Chia J.-S., Du J.-L., Hsu W.-B., Sun A., Chiang C.-P., Wang W.-B., Inhibition of metastasis, angiogenesis, and tumor growth by Chinese herbal cocktail Tien-Hsien Liquid. BMC Cancer 2010 10, article 175 2-s2.0-77951581527 10.1186/1471-2407-10-175
3. Wagner H., Ulrich-Merzenich G., Synergy research: approaching a new generation of phytopharmaceuticals. Phytomedicine 2009 16 2-3 97 110 2-s2.0-59849116161 10.1016/j.phymed.2008.12.018
4. Faivre S., Djelloul S., Raymond E., New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors. Seminars in Oncology 2006 33 4 407 420 2-s2.0-33746544343 10.1053/j.seminoncol.2006.04.005 (Pubitemid 44142738)
5. Sathornsumetee S., Therapeutic strategies to target multiple kinases in glioblastoma. Anti-Cancer Agents in Medicinal Chemistry 2011 11 8 700 711 2-s2.0-80053521874
6. Lee Y. J., Kim N. S., Kim H., Cytotoxic and anti-inflammatory constituents from the seeds of Descurainia sophia. Archives of Pharmacal Ressearch 2013 36 5 536 541
7. Chen Y. Q., Li R. Z., Wang Y. W., Identification of cardiac glycosides from the seeds of Descurainia sophia L. Webb. Acta Pharmaceutica Sinica 1981 16 1 62 64 2-s2.0-0019406148
8. Sun K., Li X., Liu J.-M., Wang J.-H., Li W., Sha Y., A novel sulphur glycoside from the seeds of Descurainia sophia (L.). Journal of Asian Natural Products Research 2005 7 6 853 856 2-s2.0-28944452307 10.1080/ 1028602042000204072 (Pubitemid 41783477)
9. Sun K., Li X., Li W., Liu J.-M., Wang J.-H., Sha Y., A new nor-lignan from the seeds of Descurainia sophia. Natural Product Research 2006 20 6 519 522 2-s2.0-33646715093 10.1080/14786410500045309 (Pubitemid 43731126)
10. Sun K., Li X., Li W., Wang J., Liu J., Sha Y., Two new lactones and one new aryl-8-oxa-bicyclo[3,2,1]oct-3-en-2-one from Descurainia sophia. Chemical and Pharmaceutical Bulletin 2004 52 12 1483 1486 2-s2.0-21644447487 10.1248/cpb.52.1483 (Pubitemid 41364432)
11. Ehrman T. M., Barlow D. J., Hylands P. J., In silico search for multi-target anti-inflammatories in Chinese herbs and formulas. Bioorganic and Medicinal Chemistry 2010 18 6 2204 2218 2-s2.0-77649236726 10.1016/j.bmc.2010. 01.070
12. Lee Y. J., Kim J., Yi J. M., Anti-proliferative neolignans from Saururus chinensis against human cancer cell lines. Biological & Pharmaceutical Bulletin 2012 35 8 1361 1366
13. Schroeder A., Mueller O., Stocker S., Salowsky R., Leiber M., Gassmann M., Lightfoot S., Menzel W., Granzow M., Ragg T., The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Molecular Biology 2006 7, article 3 2-s2.0-33645241407 10.1186/1471-2199-7-3
14. Bolstad B. M., Irizarry R. A., Åstrand M., Speed T. P., A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003 19 2 185 193 2-s2.0-0037316303 10.1093/bioinformatics/19.2.185 (Pubitemid 36181903)
15. Ernst J., Bar-Joseph Z., STEM: a tool for the analysis of short time series gene expression data. BMC Bioinformatics 2006 7, article 191 2-s2.0-33646344978 10.1186/1471-2105-7-191
16. Raponi M., Zhang Y., Yu J., Chen G., Lee G., Taylor J. M. G., MacDonald J., Thomas D., Moskaluk C., Wang Y., Beer D. G., Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung. Cancer Research 2006 66 15 7466 7472 2-s2.0-33747878451 10.1158/0008-5472.CAN-06-1191 (Pubitemid 44289200)
17. Dennis G. Jr., Sherman B. T., Hosack D. A., Yang J., Gao W., Lane H. C., Lempicki R. A., DAVID: database for annotation, visualization, and integrated discovery. Genome Biology 2003 4 5, article P3 2-s2.0-0038005018
18. Zeeberg B. R., Qin H., Narasimhan S., Sunshine M., Cao H., Kane D. W., Reimers M., Stephens R. M., Bryant D., Burt S. K., Elnekave E., Hari D. M., Wynn T. A., Cunningham-Rundles C., Stewart D. M., Nelson D., Weinstein J. N., High-throughput GoMiner, an "industrial-strength" integrative gene ontology tool for interpretation of multiple-microarray experiments, with application to studies of Common Variable Immune Deficiency (CVID). BMC Bioinformatics 2005 6, article 168 2-s2.0-23044478689 10.1186/1471-2105-6-168 (Pubitemid 41372497)
19. Supek F., Bošnjak M., Škunca N., Šmuc T., Revigo summarizes and visualizes long lists of gene ontology terms. PLoS ONE 2011 6 7 2-s2.0-79960610118 10.1371/journal.pone.0021800 e21800
20. Tarca A. L., Draghici S., Khatri P., Hassan S. S., Mittal P., Kim J.-S., Kim C. J., Kusanovic J. P., Romero R., A novel signaling pathway impact analysis. Bioinformatics 2009 25 1 75 82 2-s2.0-58049215467 10.1093/ bioinformatics/btn577
21. Lee S. Y., Song K. H., Koo I., Comparison of pathways associated with hepatitis B- and C-infected hepatocellular carcinoma using pathway-based class discrimination method. Genomics 2012 99 6 347 354
22. Veerla S., Höglund M., Analysis of promoter regions of co-expressed genes identified by microarray analysis. BMC Bioinformatics 2006 7, article 384 2-s2.0-33748351992 10.1186/1471-2105-7-384 (Pubitemid 44336318)
23. Sukhatme V. P., Chan B., Glycolytic cancer cells lacking 6-phosphogluconate dehydrogenase metabolize glucose to induce senescence. FEBS Letters 2012 586 16 2389 2395
24. Zhao W., Hu L., Xu J., Polymorphisms in the base excision repair pathway modulate prognosis of platinum-based chemotherapy in advanced non-small cell lung cancer. Cancer Chemotherpy and Pharmacology 2013 71 5 1287 1295
25. Kiyohara C., Takayama K., Nakanishi Y., Association of genetic polymorphisms in the base excision repair pathway with lung cancer risk: a meta-analysis. Lung Cancer 2006 54 3 267 283 2-s2.0-33750311904 10.1016/j.lungcan.2006.08.009 (Pubitemid 44634141)
26. Lu Z., Ding L., Hong H., Hoggard J., Lu Q., Chen Y.-H., Claudin-7 inhibits human lung cancer cell migration and invasion through ERK/MAPK signaling pathway. Experimental Cell Research 2011 317 13 1935 1946 2-s2.0-79959354209 10.1016/j.yexcr.2011.05.019
27. Ji H., Wang Z., Perera S. A., Li D., Liang M.-C., Zaghlul S., McNamara K., Chen L., Albert M., Sun Y., Al-Hashem R., Chirieac L. R., Padera R., Bronson R. T., Thomas R. K., Garraway L. A., Jänne P. A., Johnson B. E., Chin L., Wong K.-K., Mutations in BRAF and KRAS converge on activation of the mitogen-activated protein kinase pathway in lung cancer mouse models. Cancer Research 2007 67 10 4933 4939 2-s2.0-34250340783 10.1158/0008-5472.CAN-06-4592 (Pubitemid 46910201)
28. Adjei A. A., The role of mitogen-activated ERK-kinase inhibitors in lung cancer therapy. Clinical Lung Cancer 2005 7 3 221 223 2-s2.0-33244482181 10.3816/CLC.2005.n.040 (Pubitemid 43279873)
29. Mohan S., Abdelwahab S. I., Cheah S. C., Apoptosis effect of girinimbine isolated from Murraya koenigii on lung cancer cells in vitro. Evididence-Based Complementary and Alternative Medicine 2013 2013 12 10.1155/2013/689865 689865
30. Ho Y. F., Karsani S. A., Yong W. K., Abd Malek S. N., Induction of apoptosis and cell cycle blockade by helichrysetin in a549 human lung adenocarcinoma cells. Evididence-Based Complementary and Alternative Medicine 2013 2013 10 10.1155/2013/857257 857257
31. Choedon T., Dolma D., Kumar V., Pro-apoptotic and anticancer properties of thapring-a Tibetan herbal formulation. Journal of Ethnopharmacology 2011 137 1 320 326 2-s2.0-80052035791 10.1016/j.jep.2011.05.031
32. Shepherd F. A., Douillard J.-Y., Blumenschein G. R. Jr., Immunotherapy for non-small cell lung cancer: novel approaches to improve patient outcome. Journal of Thoracic Oncology 2011 6 10 1763 1773 2-s2.0-80052960634 10.1097/JTO.0b013e31822e28fc
33. Mazzoccoli G., Grilli M., Carughi S., Puzzolante F., De Cata A., La Viola M., Giuliani A., Urbano N., Tarquini R., Perfetto F., Immune system alterations in lung cancer patients. International Journal of Immunopathology and Pharmacology 2003 16 2 167 174 2-s2.0-10744228969 (Pubitemid 36850857)